|
|
|
|
|
|
Sponsored by: |
University Hospital, Strasbourg, France |
Information provided by: | University Hospital, Strasbourg, France |
ClinicalTrials.gov Identifier: | NCT00411112 |
More than 20% of patients operated on for colon cancer without node metastasis will develop visceral metastases. The purpose of the study is to determine sentinel lymph nodes with two methods: blue injection and isotopic detection. Sentinel nodes will then be analyzed by immunohistochemy to detect micrometastases. No adjuvant therapy will be proposed to the patient if there are only node's micrometastases and survival will be analyzed in regard to the presence of these micrometastasis.
Condition | Intervention |
Colon Cancer |
Procedure: blue and isotopic detection of sentinel lymph nodes |
MedlinePlus related topics: | Cancer |
ChemIDplus related topics: | Iso-sulfan blue |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Sentinel Node Study in Colon Cancer Surgery |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Cécile Brigand, MD | 3 33 88 12 72 36 | cecile.brigand@chru-strasbourg.fr |
France | |||||
Service de Chirurgie Générale et Digestive - Hôpital de Hautepierre | Recruiting | ||||
Strasbourg, France, 67098 | |||||
Contact: Cécile Brigand, MD 33.3.88.12.72.36 cecile.brigand@chru-strasbourg.fr | |||||
Sub-Investigator: Christian Meyer, MD | |||||
Sub-Investigator: Serge Rohr, MD | |||||
Principal Investigator: Cécile Brigand, MD |
University Hospital, Strasbourg, France |
Study Director: | Cécile Brigand, MD | Hôpitaux Universitaires de Strasbourg |
Study ID Numbers: | 3737 |
First Received: | December 12, 2006 |
Last Updated: | February 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00411112 |
Health Authority: | France: Ministry of Health |
|
|
|
|